Get informed when a big investor buys or sells
+ Follow16.93
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
Pharma Mar, S.A. (PHMMF) currently reports a P/E ratio of 16.93. That is below the Healthcare sector average of 21.65. Use the charts on this page to explore Pharma Mar, S.A.'s P/E ratio history and peer comparisons.
Pharma Mar, S.A.'s P/E ratio of 16.93 is lower than the Healthcare sector average of 21.65. That is roughly 21.8% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
The P/E ratio is a valuation multiple that relates Pharma Mar, S.A.'s market price to a fundamental measure such as earnings, sales, or book value. At 16.93, PHMMF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.
Start with the current P/E ratio of 16.93, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 21.65. From there, open related valuation or income-statement pages for Pharma Mar, S.A., and consider following PHMMF for alerts when major investors trade the stock.
Pharma Mar, S.A. is classified in the Healthcare sector. On P/E ratio, it currently shows 16.93 versus a sector average near 21.65. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PHMMF with unrelated industries.